🏥
🏥 Health
Alzheimer's drugs that slow the disease reach pharmacy shelves — is a cure in sight?
Two drugs — lecanemab and donanemab — that actually slow the progression of Alzheimer's disease have reached pharmacy shelves in recent years, marking a turning point for patients and families. New blood tests are also being developed to identify at-risk individuals earlier in life, before symptoms appear. Scientists are cautiously optimistic, describing a cure as within reach even if not yet fully realised.
Similar stories
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!